Records containing: Huntington's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-09-17A Multi-Center, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Pridopidine in Patients With Huntington's Disease (Open PRIDE-HD)
-
CLINICAL_TRIALS study record update · 2021-08-09The Effect of Video Game Biofeedback Modulated Exercise (ViBE)on Dynamic Balance and Gait in Individuals With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2021-07-19A Phase 2, Dose-Finding, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study, Evaluating the Safety and Efficacy of Pridopidine 45, 67.5, 90, and 112.5 mg Twice-Daily vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2021-01-19An Open-Label Extension Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)
-
CLINICAL_TRIALS study record update · 2021-01-05A Pilot Study of Memantine for Cognitive and Behavioral Dysfunction in Huntington's Disease"
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-10-22ClinicalTrials.gov study NCT02550275
-
CLINICAL_TRIALS study record update · 2020-04-20Electronic-health Application To Measure Outcomes REmotely Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-01-22Brain Stimulation in Movement Disorders
-
CLINICAL_TRIALS study record update · 2019-10-10Follow-up Measurement of Brain Phosphodiesterase 10 A (PDE10A) Enzyme Levels in Huntington´s Disease Gene Expansion Carriers, 18 to 28 Months After Initial Positron Emission Tomography (PET) Measurement in CHDIKI1201/PET-HD-PDE10A (NCT02061722)
-
CLINICAL_TRIALS study record update · 2019-06-19A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Laquinimod (0.5, 1.0 and 1.5 mg/Day) as Treatment in Patients With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2019-05-31A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 443139 in Patients With Early Manifest Huntington's Disease
-
CLINICAL_TRIALS study record update · 2019-05-30Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage Huntington's Disease
-
CLINICAL_TRIALS study record update · 2019-05-10Exploring Computerised Cognitive Training for People With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2018-10-22Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2018-10-16A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
-
CLINICAL_TRIALS study record update · 2018-09-26A Single-Arm Prospective Investigation of the Effects of Laughter Therapy on Mood, Stress, and Self-Efficacy in People With Central Nervous System Disorders.
-
CLINICAL_TRIALS study record update · 2018-06-13Exercise Effects in Huntington's Disease
-
CLINICAL_TRIALS study record update · 2018-04-23An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
-
CLINICAL_TRIALS study record update · 2018-01-29A Dose Escalation, Proof of Concept, Phase IIa Study to Investigate the Safety and Tolerability, the Pharmacokinetic and the Pharmacodynamic of BN82451B, Administered Twice Daily Over 4 Weeks, in Male Patients With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2017-12-14A Phase 2, Double-blind Randomized, Sequential Treatment Group, Placebo-controlled Study To Evaluate The Safety, Tolerability And Brain Cortico-striatal Function Of 2 Doses Of Pf-02545920 In Subjects With Early Huntington's Disease
-
CLINICAL_TRIALS study record update · 2017-11-17A Phase 2, Randomized, Placebo Controlled, Double Blind Proof-of-concept Study Of The Efficacy And Safety Of Pf-02545920 In Subjects With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2017-10-19Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
-
CLINICAL_TRIALS study record update · 2017-09-25A Multi-Center, Double-Blind, Randomized, Parallel Group Tolerability Study of Coenzyme Q10 (UbiquinonE)in PRE-manifest Huntington's Disease
-
CLINICAL_TRIALS study record update · 2017-09-15REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)
-
CLINICAL_TRIALS study record update · 2017-08-08FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease